

AIM-listed healthcare equipment firm Akers Biosciences has entered into an agreement with medical devices market developer Jai Capital to launch the g...


LONDON (Alliance News) - Akers Biosciences Inc, which recently listed on Nasdaq, Wednesday reported a first-quarter net loss of USD595,600, mainly due...


LONDON (Alliance News) - Akers Biosciences Inc Wednesday said it had signed a deal whereby Dubai-based Thirty Six Strategies General Trading LLC will ...


AIM- and Nasdaq-listed healthcare equipment firm Akers Biosciences has signed a three-year distribution agreement to sell its products in Australia, S...


LONDON (Alliance News) - Akers Biosciences Inc said Wednesday that it has begun clinical trials in the US for its PIFA PLUSS chlamydia assay, a test f...


LONDON (Alliance News) - Akers Biosciences Inc Friday posted a narrowed pretax loss for 2013, as it saw revenues more than double, driven by sales of ...


LONDON (Alliance News) Akers Biosciences Wednesday said Chief Executive Thomas Nicolette will step down from the board and leave the company on March ...


LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when th...